Serodus APS
Records under this name other than the patents Serodus APS holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 5 of 5 · Back to Serodus APS
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,359,405 | Antagonists of the interleukin-1 receptor Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,834,010 | Modulators of peripheral 5-HT receptors Lapsed on the fee record Ended Nov 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 16, 2022 | From the USPTO record |
| US 7,244,701 | Diuretic peptide conjugate Term ended Term ended Jul 1, 2021 · From the USPTO record | Term ended | Term ended Jul 1, 2021 | From the USPTO record |
| US 7,550,425 | Diuretic peptide conjugates Lapsed on the fee record Ended Jun 23, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jun 23, 2021 | From the USPTO record |
| US 8,829,028 | 5-HT4 receptor antagonists for the treatment of heart failure Lapsed on the fee record Ended Sep 9, 2018 · From the USPTO record | Lapsed on the fee record | Ended Sep 9, 2018 | From the USPTO record |